Noncanonical Amino Acids in Oral Peptide Drug Design

Macrocyclic peptides achieve therapeutic efficacy through precisely engineered molecular architectures that simultaneously optimize target binding, metabolic stability, and membrane permeability. The transition from linear to cyclic topology fundamentally alters peptide behavior across three critical axes: (1) conformational preorganization reduces entropic penalties during target engagement, improving binding affinity by 10-1000-fold; (2) cyclization restricts protease recognition sites and shields cleavable bonds, extending half-lives from minutes to hours [5,6]; and (3) constrained geometries reduce polar surface area and hydrogen-bond donor count, enhancing passive membrane permeability essential for oral bioavailability.